Overview

Statin Therapy Versus Placebo Prior to Prostatectomy

Status:
Completed
Trial end date:
2017-04-30
Target enrollment:
Participant gender:
Summary
This is a randomized trial comparing the effect of oral simvastatin versus placebo on targets of the mevalonate pathway in men undergoing a prostatectomy as planned management for prostate cancer. Observed tissue effects will be correlated with changes in serum cholesterol and low-density lipoprotein.
Phase:
N/A
Details
Lead Sponsor:
VA Office of Research and Development
Collaborator:
Oregon Health and Science University
Treatments:
Simvastatin